The Chiral Chromatography Columns Market size is estimated at USD 104.17 million in 2024, and is expected to reach USD 132.13 million by 2029, growing at a CAGR of 4.87% during the forecast period (2024-2029).
The COVID-19 pandemic is likely to have a slightly positive effect on the market. Robust analytical techniques were used by researchers worldwide in the creation of efficient COVID-19 treatments. As per the study report published by Scientific Reports in April 2021, the normal phase chiral high-performance liquid chromatography (HPLC) method provides an essential analytical tool for the preclinical and clinical evaluation of hydroxychloroquine that was tested in the clinics for the potential treatment of COVID-19. Hence the advanced techniques in chiral chromatography were expected to have a positive impact on the market during the pandemic. As the trials are still ongoing for the treatment of COVID-19 it is expected to have a significant impact on the market over the coming years.
The major factors attributing to the growth of the chiral chromatography columns market are the advancement in the technology of chromatography instruments and the significance of chromatography-based studies in drug approval. Higher government expenditure, funding, and subsidies have encouraged pharmaceutical and biotechnology industries to use the advanced chromatographic method that is propelling market growth.
For instance, as per the report published by the Multidisciplinary Digital Publishing Institute in December 2021, on five distinct polysaccharide-type chiral selectors, four phthalimide-analog thalidomide derivatives were successfully separated through enantioseparation in a polar organic mobile phase mode which opens up the possibility of a new type of chiral screening strategy. Hence new types of strategies can be identified through the chiral chromatography on the drug molecules and are expected to drive the market to grow.
Moreover, new collaborations and acquisitions among the major players are also expected to have a positive impact on the market. For instance, in February 2022, Sartorius closed the acquisition of the Novasep chromatography division following approval by the United States Federal Trade Commission. The portfolio acquired comprises chromatography systems primarily suited for smaller biomolecules, such as oligonucleotides, peptides, and insulin, as well as innovative systems for the continuous manufacturing of biologics. Thus, due to the above-mentioned factors, the studied market is expected to be significantly driven.
However, the rising price of the equipment is expected to hinder the market growth.
The chiral chromatography columns market is moderately competitive and consists of major players. In terms of market share, a few major players are currently dominating the market. Some prominent players are vigorously making acquisitions and new product launches with other companies to consolidate their market positions across the globe. Some of the companies which are currently dominating the market are Merck KGaA, Shimadzu Corporation, Daicel Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Danaher Corporation (Phenomenex Inc.), General Electric Company (GE Healthcare), and Agilent Technologies.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook